标题
Targeting the endocannabinoid system: to enhance or reduce?
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 7, Issue 5, Pages 438-455
出版商
Springer Nature
发表日期
2008-04-30
DOI
10.1038/nrd2553
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program
- (2008) L. Van Gaal et al. DIABETES CARE
- Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids
- (2008) Carol A. Rouzer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists
- (2007) C A Lunn et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptor-mediated migration of immune cells: it can go either way
- (2007) A M Miller et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostamides (prostaglandin-ethanolamides) and their pharmacology
- (2007) D F Woodward et al. BRITISH JOURNAL OF PHARMACOLOGY
- The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation
- (2007) F Comelli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rimonabant: more than an anti-obesity drug?
- (2007) B Costa BRITISH JOURNAL OF PHARMACOLOGY
- Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats
- (2007) T Croci et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk
- (2007) R M Evans et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
- (2007) M D Jhaveri et al. BRITISH JOURNAL OF PHARMACOLOGY
- The complications of promiscuity: endocannabinoid action and metabolism
- (2007) S P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
- (2007) S E O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: A critical revisitation
- (2007) Giorgio Ortar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis
- (2007) J. Ludovic Croxford et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple pathways involved in the biosynthesis of anandamide
- (2007) Jie Liu et al. NEUROPHARMACOLOGY
- Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
- (2007) Fabricio A. Moreira et al. NEUROPHARMACOLOGY
- Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice
- (2007) David J. Rademacher et al. NEUROPHARMACOLOGY
- The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level
- (2007) Gyöngyi Horvath et al. PAIN
- Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice
- (2007) Michel A. Steiner et al. PSYCHONEUROENDOCRINOLOGY
- Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
- (2006) Leon Chang et al. BRITISH JOURNAL OF PHARMACOLOGY
- AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain
- (2006) Barbara Costa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid pharmacology: the first 66 years
- (2006) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started